Cite
HARVARD Citation
Wilkins, A. et al. (2015). Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet oncology. 16 (16), pp. 1605-1616. [Online].